CN112933169A - Traditional Chinese medicine compatible component for treating chronic wound - Google Patents
Traditional Chinese medicine compatible component for treating chronic wound Download PDFInfo
- Publication number
- CN112933169A CN112933169A CN202010164496.1A CN202010164496A CN112933169A CN 112933169 A CN112933169 A CN 112933169A CN 202010164496 A CN202010164496 A CN 202010164496A CN 112933169 A CN112933169 A CN 112933169A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- traditional chinese
- chinese medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 72
- 206010052428 Wound Diseases 0.000 title claims abstract description 70
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 230000001684 chronic effect Effects 0.000 title claims abstract description 44
- 239000000843 powder Substances 0.000 claims abstract description 98
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 25
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 24
- 229940105847 calamine Drugs 0.000 claims abstract description 24
- 229910052864 hemimorphite Inorganic materials 0.000 claims abstract description 24
- 235000014692 zinc oxide Nutrition 0.000 claims abstract description 24
- 239000011787 zinc oxide Substances 0.000 claims abstract description 24
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910021538 borax Inorganic materials 0.000 claims abstract description 20
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 20
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 20
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 19
- 241001071917 Lithospermum Species 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 18
- 206010004542 Bezoar Diseases 0.000 claims abstract description 16
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 16
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 16
- 239000009136 dragon's blood Substances 0.000 claims abstract description 16
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 15
- 241000131329 Carabidae Species 0.000 claims abstract description 10
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 10
- 240000001910 Momordica cochinchinensis Species 0.000 claims abstract description 9
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 9
- 240000004980 Rheum officinale Species 0.000 claims abstract description 8
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 8
- 239000002674 ointment Substances 0.000 claims description 16
- 241000563984 Ampelopsis Species 0.000 claims description 14
- 244000173853 Sanguisorba officinalis Species 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 238000000227 grinding Methods 0.000 claims description 12
- 241000219061 Rheum Species 0.000 claims description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000009815 Momordica Nutrition 0.000 claims description 8
- 241000218984 Momordica Species 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 235000008216 herbs Nutrition 0.000 claims description 7
- 241000123835 Ampelopsis japonica Species 0.000 claims description 6
- 241001489978 Eupolyphaga Species 0.000 claims description 6
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 6
- 238000001354 calcination Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229940099259 vaseline Drugs 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 230000000840 anti-viral effect Effects 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 240000003173 Drymaria cordata Species 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000009416 jing wan hong Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004306 sulfadiazine Drugs 0.000 claims description 3
- 210000002268 wool Anatomy 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 240000002045 Guettarda speciosa Species 0.000 claims 4
- 241000581682 Sanguisorba Species 0.000 claims 1
- 239000012674 herbal formulation Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 35
- 230000001737 promoting effect Effects 0.000 abstract description 29
- 208000002193 Pain Diseases 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 26
- 230000036407 pain Effects 0.000 abstract description 26
- 230000035876 healing Effects 0.000 abstract description 20
- 230000008961 swelling Effects 0.000 abstract description 15
- 244000061520 Angelica archangelica Species 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 10
- 231100000331 toxic Toxicity 0.000 abstract description 7
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 230000017423 tissue regeneration Effects 0.000 abstract description 5
- 241000219099 Parthenocissus quinquefolia Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 description 17
- 230000004054 inflammatory process Effects 0.000 description 16
- 208000025865 Ulcer Diseases 0.000 description 15
- 206010042674 Swelling Diseases 0.000 description 14
- 230000003179 granulation Effects 0.000 description 13
- 238000005469 granulation Methods 0.000 description 13
- 230000000144 pharmacologic effect Effects 0.000 description 11
- 231100000397 ulcer Toxicity 0.000 description 11
- 239000002398 materia medica Substances 0.000 description 10
- 230000003211 malignant effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 208000004210 Pressure Ulcer Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 230000001338 necrotic effect Effects 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 230000036269 ulceration Effects 0.000 description 4
- UCZJPQIEFFTIEV-UHFFFAOYSA-N 5-methoxy-6-methyl-2-phenylchromen-7-one Chemical compound C=1C=C2C(OC)=C(C)C(=O)C=C2OC=1C1=CC=CC=C1 UCZJPQIEFFTIEV-UHFFFAOYSA-N 0.000 description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 3
- 241000118825 Alkanna tinctoria Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 239000009112 niuhuang Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- MHVJRKBZMUDEEV-UHFFFAOYSA-N (-)-ent-pimara-8(14),15-dien-19-oic acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)C=C1CC2 MHVJRKBZMUDEEV-UHFFFAOYSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 2
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- VOMDIEGPEURZJO-UHFFFAOYSA-N Deoxyshikonin Chemical compound C1=CC(O)=C2C(=O)C(CCC=C(C)C)=CC(=O)C2=C1O VOMDIEGPEURZJO-UHFFFAOYSA-N 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- -1 caladiene Chemical compound 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- MXYATHGRPJZBNA-KRFUXDQASA-N isopimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@@](C=C)(C)CC2=CC1 MXYATHGRPJZBNA-KRFUXDQASA-N 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000003752 saphenous vein Anatomy 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MHVJRKBZMUDEEV-APQLOABGSA-N (+)-Pimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@](C=C)(C)C=C2CC1 MHVJRKBZMUDEEV-APQLOABGSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- YLKVIMNNMLKUGJ-FPLPWBNLSA-N (15:1)-Cardanol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-FPLPWBNLSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- YLKVIMNNMLKUGJ-UHFFFAOYSA-N 3-Delta8-pentadecenylphenol Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- JOWXBGIZDALBJW-UHFFFAOYSA-N 3h-dioxepine Chemical compound C1OOC=CC=C1 JOWXBGIZDALBJW-UHFFFAOYSA-N 0.000 description 1
- MXYATHGRPJZBNA-UHFFFAOYSA-N 4-epi-isopimaric acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)CC1=CC2 MXYATHGRPJZBNA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010048946 Anal abscess Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 102000004411 Antithrombin III Human genes 0.000 description 1
- 108090000935 Antithrombin III Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000030016 Avascular necrosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 206010068653 Bone abscess Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001161070 Calomela Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 241001448862 Croton Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- QUUCYKKMFLJLFS-UHFFFAOYSA-N Dehydroabietan Natural products CC1(C)CCCC2(C)C3=CC=C(C(C)C)C=C3CCC21 QUUCYKKMFLJLFS-UHFFFAOYSA-N 0.000 description 1
- NFWKVWVWBFBAOV-UHFFFAOYSA-N Dehydroabietic acid Natural products OC(=O)C1(C)CCCC2(C)C3=CC=C(C(C)C)C=C3CCC21 NFWKVWVWBFBAOV-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 108010066486 EGF Family of Proteins Proteins 0.000 description 1
- 102000018386 EGF Family of Proteins Human genes 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000735432 Hydrastis canadensis Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 240000005779 Jasminum multiflorum Species 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- WEQUVWKUIZCSNI-UHFFFAOYSA-N Ligustilide dimer Natural products O1C(=O)C(C=CCC2)=C2C21C(CCC)C13CCC2C=C3C(=O)OC1=CCCC WEQUVWKUIZCSNI-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 description 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 229930190125 Sanguisorbin Natural products 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000003610 TRPM8 Human genes 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 101150111302 Trpm8 gene Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- UTOUNDHZJFIVPK-QGZVFWFLSA-N [(1r)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 3-methylbutanoate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](CC=C(C)C)OC(=O)CC(C)C)=CC(=O)C2=C1O UTOUNDHZJFIVPK-QGZVFWFLSA-N 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- QFHMNFAUXJAINK-UHFFFAOYSA-N [1-(carbamoylamino)-2-methylpropyl]urea Chemical group NC(=O)NC(C(C)C)NC(N)=O QFHMNFAUXJAINK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910001586 aluminite Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 150000001440 androstane derivatives Chemical class 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000000141 anti-hypoxic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229960005348 antithrombin iii Drugs 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- BGLUXFNVVSVEET-UHFFFAOYSA-N beta-angelica lactone Chemical compound CC1OC(=O)C=C1 BGLUXFNVVSVEET-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003809 bile pigment Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 201000004308 chancroid Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- NFWKVWVWBFBAOV-MISYRCLQSA-N dehydroabietic acid Chemical compound OC(=O)[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 NFWKVWVWBFBAOV-MISYRCLQSA-N 0.000 description 1
- 229940118781 dehydroabietic acid Drugs 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000005679 goldenseal Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000005550 inflammation mediator Substances 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- VNYSSYRCGWBHLG-AMOLWHMGSA-M leukotriene B4(1-) Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC([O-])=O VNYSSYRCGWBHLG-AMOLWHMGSA-M 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 description 1
- 125000004370 n-butenyl group Chemical group [H]\C([H])=C(/[H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000009581 negative-pressure wound therapy Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002856 peripheral neuron Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- NYRISADACLJHMJ-UHFFFAOYSA-N pinosylvic acid Natural products OC(=O)C1=C(O)C=C(O)C=C1C=CC1=CC=CC=C1 NYRISADACLJHMJ-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- UTOUNDHZJFIVPK-UHFFFAOYSA-N shikonin isovalerate Natural products C1=CC(O)=C2C(=O)C(C(CC=C(C)C)OC(=O)CC(C)C)=CC(=O)C2=C1O UTOUNDHZJFIVPK-UHFFFAOYSA-N 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- ROCZYNYGPDAYRQ-QGYXGAFPSA-N stigmasterol d-glucoside Natural products CC[C@H](C=C[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5C)C(C)C ROCZYNYGPDAYRQ-QGYXGAFPSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000035921 thrombopoiesis Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Abstract
The invention provides a traditional Chinese medicine compatible component for treating chronic wound, which relates to the technical field of traditional Chinese medicine formulas and is prepared from the following components in parts by weight: 10-50 parts of lithospermum, 0.1-10 parts of bezoar, 30-90 parts of borneol, 0.1-1.0 part of pearl powder, 0.2-5 parts of amber powder, 30-80 parts of angelica, 50-120 parts of calcined calamine powder, 0.1-0.8 part of musk, 10-40 parts of dragon's blood, 5-20 parts of rheum officinale, 5-20 parts of garden burnet, 10-40 parts of Japanese ampelopsis root, 1-20 parts of ground beetle, 10-40 parts of honeysuckle, 1-5 parts of momordica cochinchinensis seed and 5-20 parts of borax; the invention applies the ideas of promoting blood circulation to remove blood stasis, promoting tissue regeneration and healing sore, clearing away heat and toxic materials, and relieving swelling and pain in traditional Chinese medicine, is used for healing wound surfaces, and has obvious curative effect on the wound surfaces which are not healed for a long time.
Description
Technical Field
The invention mainly relates to the technical field of traditional Chinese medicine formulas for treating chronic wounds, in particular to a traditional Chinese medicine compatible component for treating chronic wounds.
Background
The chronic wound surface is a kind of disease or complication which relates to various disciplines and a plurality of specialties, has complicated disease conditions and is difficult to handle, for example, the chronic wound surface such as diabetic foot, pressure sore, venous ulcer, limb arterial avascular necrosis and the like, and the chronic wound caused by various wounds, burns, scalds, non-healing wounds after operation, bedsore and the like are increased, the diseases are dispersed in the related specialties before, lack of unified diagnosis and treatment specifications, bring difficulties to diagnosis and treatment, delay treatment, cause huge social and family economic burden, seriously affect the life quality of patients, and finally cause amputation and even death. In recent years, along with the communication and fusion among multiple disciplines, the innovation and development of technology and materials, the cognition and diagnosis and treatment of diseases are continuously improved, and the disease which is not concerned about for many years, namely chronic wound, is more and more emphasized. At present, the main methods for treating chronic wounds are as follows:
debridement; in the most basic treatment, contaminated, lost blood supply and necrotic tissue can be removed. The curative effect is not exact, the time is longer, the financial resources are consumed, and larger scars can be left.
Negative pressure wound therapy; physical therapy methods to alleviate infection by inhibiting bacterial proliferation. But the use of the wound surface infected by anaerobic bacteria is not recommended, the treatment cost is high, and the popularization cannot be realized.
A growth factor; play an important role in cell division, migration, differentiation, protein expression and enzyme production. The wound healing is promoted by stimulating vascular proliferation, cell proliferation, chemotactic inflammatory cells and fibroblasts. The chronic wound surface is damaged due to the damage of the wound surface environment, the chronic wound surface is lack of growth factors or the growth factors cannot play a role, and particularly the expression levels of epidermal growth factors, fibroblast growth factors, vascular endothelial growth factors and the like are reduced.
Platelet rich plasma; taking autologous plasma of a patient, and centrifuging and processing the autologous plasma by an instrument to obtain the autologous plasma. Is not suitable for acute wound. Unstable curative effect, complex operation and high cost.
High pressure oxygen; promoting fibroblast proliferation, enhancing immunity, and stimulating angiogenesis. The clinical effect is not good, and a patient needs to be placed in a high-pressure oxygen-tight chamber, so that a plurality of adverse reactions exist.
But also grafts of skin grafting, nerves, blood vessels, tendons and the like, however, the prior treatment method is lack of universality and universality, high in treatment cost, long in time consumption and uncertain in curative effect.
Disclosure of Invention
The invention provides a traditional Chinese medicine compatibility component for treating chronic wounds in order to overcome the defects in the background technology, and the traditional Chinese medicine compatibility component is used for healing wounds by applying the concepts of promoting blood circulation to remove blood stasis, promoting granulation and healing sores, clearing away heat and toxic materials, and relieving swelling and pain, and has a remarkable curative effect on long-term unhealed wounds.
In order to achieve the purpose, the invention provides the following technical scheme:
a traditional Chinese medicine compatible component for treating chronic wound surfaces is prepared from the following components in parts by weight: 10-50 parts of lithospermum, 0.1-10 parts of bezoar, 30-90 parts of borneol, 0.1-1.0 part of pearl powder, 0.2-5 parts of amber powder, 30-80 parts of angelica, 50-120 parts of calcined calamine powder, 0.1-0.8 part of musk, 10-40 parts of dragon's blood, 5-20 parts of rheum officinale, 5-20 parts of garden burnet root, 10-40 parts of Japanese ampelopsis root, 1-20 parts of ground beetle, 10-40 parts of honeysuckle, 1-5 parts of momordica cochinchinensis seed and 5-20 parts of borax.
The traditional Chinese medicine compatible component for treating chronic wound is prepared from the following components in parts by weight: 15-40 parts of lithospermum, 0.3-10 parts of bezoar, 40-80 parts of borneol, 0.3-0.7 part of pearl powder, 0.2-3 parts of amber powder, 40-60 parts of angelica, 70-100 parts of calcined calamine powder, 0.2-0.4 part of musk, 15-30 parts of dragon's blood, 8-18 parts of rheum officinale, 10-20 parts of garden burnet root, 15-30 parts of Japanese ampelopsis root, 5-15 parts of ground beetle, 15-30 parts of honeysuckle, 1-5 parts of momordica seed and 10 parts of borax.
The traditional Chinese medicine compatible component for treating chronic wound is prepared from the following components in parts by weight: 15-30 parts of lithospermum, 0.3-10 parts of bezoar, 30-50 parts of borneol, 0.3-0.7 part of pearl powder, 0.2-3 parts of amber powder, 40-60 parts of angelica, 90-110 parts of calcined calamine powder, 0.2-0.4 part of musk, 18-28 parts of dragon's blood, 10-15 parts of rheum officinale, 10-15 parts of garden burnet root, 20-30 parts of Japanese ampelopsis root, 8-15 parts of ground beetle, 20-30 parts of honeysuckle, 1-5 parts of momordica seed and 10 parts of borax.
The traditional Chinese medicine compatible component for treating chronic wound is prepared from the following components in parts by weight: 25 parts of lithospermum, 0.7 part of bezoar, 40 parts of borneol, 0.5 part of pearl powder, 0.5 part of amber powder, 50 parts of angelica, 108.6 parts of calcined calamine powder, 0.4 part of musk, 25 parts of dragon's blood, 13 parts of rhubarb, 13 parts of sanguisorba, 25 parts of ampelopsis japonica, 10 parts of ground beeltle, 25 parts of honeysuckle, 3 parts of momordica cochinchinensis and 10 parts of borax.
The preparation method of the traditional Chinese medicine compatible components for treating the chronic wound comprises the following steps:
s1: placing borax in a calcining pot according to the formula amount, heating with strong fire, calcining to form white snow, crisp and loose blocks, taking out, cooling, grinding, sieving with a 200-mesh sieve to obtain powder I, or adding appropriate amount of vaseline to obtain paste I;
s2: grinding Moschus, calculus bovis, radix et rhizoma Rhei, Succinum, sanguis Draxonis, Borneolum Syntheticum, radix Ampelopsis, Eupolyphaga Seu Steleophaga, and semen Momordicae into fine powder P1; pulverizing the calcined calamine powder with the formula amount into fine powder, heating 800g of vaseline and 60g of wool fat, heating to about 150 ℃, slowly adding the calcined calamine powder, stirring, cooling to about 50 ℃, adding the fine powder P1 with the formula amount, and stirring uniformly to form paste II;
s3: soaking radix Arnebiae, radix Angelicae sinensis, and flos Lonicerae in small amount of oleum Sesami for 15-30 days, boiling, cooling to 50 deg.C, keeping for about 20 min, and filtering to obtain extract III;
s4: parching radix Sangusorbae to brown, and grinding into powder IV;
s5: mixing paste I obtained from S1 or paste II obtained from powder I, S2, extract III obtained from S3 and powder IV obtained from S4 to obtain paste.
The traditional Chinese medicine compatible component preparation for treating the chronic wound is an ointment, and an equal amount of Jingwanhong ointment is added for mixing.
The application of the traditional Chinese medicine compatible components for treating chronic wound surfaces can be added with sulfadiazine ointment with the same amount to improve the antiviral effect of the ointment.
The traditional Chinese medicine compatible component for treating the chronic wound is prepared into paste and patches.
The traditional Chinese medicine compatible components are applied to treating chronic wounds.
Compared with the prior art, the invention has the beneficial effects that:
the traditional Chinese medicine for treating chronic wounds comprises 16 medicinal materials, is simple in compatibility, easy to control in medicine property and effect, and does not generate toxic or side effect due to complicated compatibility. The 16 medicinal materials comprise lithospermum, bezoar, borneol, pearl powder, amber powder, angelica, calcined calamine powder, musk, dragon's blood, rhubarb, garden burnet root, Japanese ampelopsis root, ground beetle, honeysuckle, cochinchina momordica seed and borax, wherein the medicinal materials comprise functional components for cooling blood and stopping bleeding, clearing heat and detoxifying, functional components for promoting blood circulation and removing blood stasis, functional components for promoting granulation and healing sore and functional components for diminishing inflammation and relieving pain, the scientific compatibility is realized, the effects of clearing heat and sterilizing, promoting granulation and healing sore are taken into consideration, and the curative effects of cooling blood, diminishing inflammation and the like are also realized;
wherein the effective components for cooling blood, stopping bleeding, clearing heat and detoxicating comprise radix Arnebiae, calculus bovis, Borneolum Syntheticum, Margarita powder, and radix Sangusorbae; the effective components for promoting blood circulation and removing blood stasis comprise Succinum powder and Eupolyphaga Seu Steleophaga; the effective components for promoting granulation and healing wound comprise radix Angelicae sinensis, calcined calamine powder, radix Ampelopsis, and sanguis Draxonis; the anti-inflammatory and analgesic effective components include Moschus, flos Lonicerae, semen Momordicae, radix et rhizoma Rhei, and Borax.
Compared with the existing products on the market, the ointment has the remarkable effects of removing the necrotic tissue and promoting tissue regeneration and diminishing inflammation; meanwhile, the peculiar smell of the wound can be removed, and a comfortable environment is created for patients and medical staff; compared with other methods in the prior art, the product has low price, universality and no special requirements on the pathogenesis and the diseased part of the wound. The compatibility of the medicinal materials can accelerate the healing of the wound surface, and has obvious curative effect on the wound surface which is not healed for a long time.
The traditional Chinese medicine compatible components can be prepared into paste and patch, the total effective rate of the wound paste and the wound patch is 100%, and the cure rate is more than 95%.
Wherein each medicinal material has the following functions:
the active ingredients of the lithospermum are mainly naphthalene pigments with strong fat solubility: comprises shikonin, acetylshikonin, beta-dimethylacrylshikonin, deoxyshikonin, isovalerylshikonin and isobutylidene, and the shikonin can cure malignant sore according to the record of the medical treatise; the compendium of materia medica records that the alkanna tinctoria has the functions of cooling blood and activating blood and benefiting large and small intestines, so that people with pockmark rash without eruption and blood heat toxin sore eruption can use the alkanna tinctoria with the action of making the medicine to erupt, blood heat toxin is excessive and stool is blocked, and people with eruption and purple black constipation can use the alkanna tinctoria; the lithospermum has good antiviral, broad-spectrum and high-efficiency antibacterial effects, and has obvious inhibiting effects on staphylococcus aureus, staphylococcus albus, streptococcus A and the like. Persistent inflammatory reaction and infection are the main reasons for chronic wound surface, so that effective inhibition of inflammatory reaction and bacteriostasis of the wound are the prerequisite for wound healing;
calculus bovis mainly comprises bile pigment (bilirubin and biliverdin), bile acid, cholesterol, fatty acid, lecithin, mucin, smooth muscle contraction substance, amino acids, carotenoid, oily cardiotonic component, inorganic component and vitamin D. The compendium of materia medica records that pimples are purple, and can be used for patients suffering from mania and delirium; bezoar antidotal pill from Baoyingdu (infant care for health): calculus bovis, radix Glycyrrhizae, flos Lonicerae, radix Glycyrrhizae, and placenta hominis by pulverizing into powder, and making honeyed pill for oral administration; the research finds that the bezoar can inhibit the inflammatory reaction. The anti-inflammatory matrix can affect charged groups of tissue proteins through the surface activity of bile acid, inhibit mutual recognition and interaction among proteins to play an anti-inflammatory role, and can also inhibit the generation of inflammation mediators leukotriene B4 and PGE to reduce the synthesis and release of Nitric Oxide (NO) and histamine; also has effects of promoting hematopoiesis, clearing away heat and toxic materials;
the borneol is mainly borneol, contains various terpenoids, has the effect of promoting transdermal penetration, and also has the effects of resisting inflammation and relieving pain; for sores and ulcers which are not healed for a long time after they are ulcerated, it is combined with niu Huang, Zhen Zhu and Galamina, such as Babaodan; bing pian (Chinese character of 'Yi Lin Shu Yao)' records that Bing pian can dispel stagnated fire, and can be used for treating epilepsy, phlegm stagnation, pharyngitis, tongue distention, toothache, deafness, nasal obstruction, conjunctival congestion, nebula, acne, insect killing, hemorrhoid, promoting growth, promoting sexual intercourse, promoting granulation, and relieving pain. Naturally dispersing and being exhausted, it is finally returned to cold; modern pharmacological studies show that borneol can promote drug absorption and relieve pain, peripheral neurons expressing TRPM8 are activated by borneol to trigger nerve discharge, cell membrane protein molecules of a type called metabotropic glutamate receptor located in spinal cord are activated, pain nerve signal transmission is inhibited finally, pain is relieved on subjective feeling, and the analgesic effect is achieved.
The pearl powder contains trace elements such as manganese, copper, zinc and the like, and the pearl powder is recorded in the book Ben Cai Hui Yan and is used for treating all the symptoms of carbuncle and sore, tendon penetration, vein ulceration, muscle damage, bone fracture, joint opening, bloody pus dripping and failure of ulceration for a long time: zhenzhu Yiqian (ground into superfine powder), and Duan Ying (dried and ground into superfine powder); melting white wax and lard oil on fire, mixing with exocarpium powder and pearl powder, and mixing. Washing the sore with pig trotter soup, applying wax oil medicine, and sticking with lead powder, sesame oil plaster; the pearl powder has the effects of calming heart, tranquilizing mind, relieving inflammation, removing toxic substances, removing malignant boil, and ulcerating internal organs; the "orthodox surgery" records pearl powder: the pearl powder treats skin and meat rot of chancroid, extremely intolerable pain, skin sore with full new meat, skin and meat rot, soup splashed with fire, and pain caused by: five cents in green jar, one money in pearl (finely ground), and two in true calomel. The three herbs are ground into thousands of turns and are as thin as flying noodles. It is applied when the skin is damaged at the beginning of malnutrition; for those with rot pain, cleaning Glycyrrhrizae radix decoction, and applying on pig spinal cord; such as those who do not suffer from skin sores, are dry blended. It can also be used for treating gynecological erosion of yin. When the soup splashes fire and burns with pain, the yuhong ointment is used for mixing and applying; modern pharmacological studies show that the pearl powder mainly has the effects of resisting inflammation, detoxifying, promoting granulation, promoting the activity of cell superoxide dismutase and resisting inflammation;
the amber powder contains resin, volatile oil, succinic acid, succinic abietic acid, succinic pinosylvic acid, succinic fatty alcohol, succinic abietic alcohol, succinic acid and the like, and also contains trace elements, and can promote blood circulation by removing blood stasis and promoting blood circulation of wound surfaces, and amber is described in the original meridian: the herb should not be administered by mistake for those who do not have blood clotting and do not have the property of removing abrasion and draining dampness. In powder with rhubarb and turtle shell, cun an ancient type of spoon below the wine is indicated for lochia in abdomen of women, which stops the blood exhaustion. For blood stasis and swelling, the abdomen is bulging and difficult to urinate, it is combined with qi-breaking herbs of Chen Xiang Dynasty. It is also ground and applied on jin Jiang to remove blood stasis without scar. "
The angelica contains ligustilide, n-butenyl lactone, angelone and other trace elements as well as vitamin B12, iron, zinc and other trace elements. In addition, ferulic acid, acetophenone, caladiene, carvacrol, guaiacol, anisic acid, angelica lactone, ligustilide dimer and the like are contained, the composition has the functions of resisting inflammation, inhibiting bacteria and the like, and the medical application is wide and the composition is compatible with the lithospermum to enhance the effect; the book of entry records: warming middle energizer to relieve pain, removing obstruction of blood, relieving spasm and sweating, treating arthralgia due to dampness, treating nausea, qi deficiency, and restoring muscle; the compendium of materia medica records that the headache, the pain of heart and abdomen, the intestine moistening, the stomach moistening, the muscles and the bones and the skin are treated. For superficial infection, pus discharge and pain relief, blood circulation and blood tonifying; the miraculous effect of Liang Fang records that Dang Gui san is used for treating bone abscess and all malignant sores: half two angelica, one two liquorice, twelve gardenia jasminoides and one momordica seed (peeled). Grinding into fine powder, taking three coins each time, and mixing with cold wine; modern pharmacological studies show that angelica has the effects of resisting anoxia, resisting inflammation, inhibiting bacteria and the like, enriching blood and activating blood.
Calcined calamine powder, described in compendium of materia Medica, has the effects of stopping bleeding, removing toxic swelling, promoting granulation, improving eyesight, removing nebula and red skin, removing dampness and removing rotten. Has antibacterial, astringent, antiseptic, and wound surface protecting effects. Is recorded in modern practical traditional Chinese medicines and used for treating chronic ulcer and lower leg ulcer with difficult healing, and has the efficacy of preventing corrosion and promoting tissue regeneration. The prescription of Imperial medicine has recorded Pingyi powder: 45 g of calamine (baked) and 15 g of keel. Grinding into fine powder, mixing with the affected part in dry form, and applying plaster; modern pharmacological studies show that the calcined calamine powder has the effects of healing sore, promoting granulation, inhibiting bacteria, astringing, preventing corrosion and protecting wound surfaces.
Musk contains muscone, musk pyridine, 11 androstane derivatives, cholesterol, fat, protein, wax and inorganic salt, and the musk recorded in Ben Cao Zheng can be used for treating skin sore, anal fistula, swelling and pain, pus, saprophy, and macula. It is suitable for patients with qi stagnation. Sealing with Moschus if skin sore is caused by mouse bite or insect bite; the musk is used for treating sore and ulcer pyogenic infections, sore throat and musk pungent and fragrant powder, has good effects of promoting blood circulation, removing stasis, relieving swelling and pain, and has good effects for oral administration and external application. For sores and ulcers, she Xiang is often combined with Xiong Huang, Ru Xiang and Mo Yao, i.e. xing Xiao Wan, or niu Huang, Ru Xiang and Mo Yao; for swollen and sore throat, she Xiang can be combined with niu Huang, Chan Su and Zhen Zhu, such as Liu Shen Wan; record musk cream in Qianjin Fang: musk is used for treating carbuncle, deep-rooted carbuncle, back and various malignant sores and removing malignant flesh: 50 g of musk, realgar, aluminite and jianzhu (a herb is Zhenzhu'). The four herbs are treated with the above herbs and sieved, and the raw meat paste is applied after the meat is cured by the pig paste.
The water-soluble polypeptide protein in musk has the effects of resisting inflammation, promoting blood circulation, dredging channels, relieving swelling and alleviating pain by reducing the generation of active lipid of neutrophils, weakening the release effect of neutrophils, reducing the release content of granules by the neutrophils and reducing the level of free calcitonin; musk has the functions of sore and ulcer pyogenic infection, anti-inflammation, detumescence and acesodyne, and has good effect for oral administration and external application.
Borax mainly contains sodium tetraborate; and also contains a small amount of impurities such as lead, copper, calcium, aluminum, iron, magnesium, silicon and the like, and the regeneration of tissue is promoted when the raw materials are calcined to wither. The compendium of materia medica records that the medicine treats the diseases of upper jiao phlegm-heat, body fluid generation, mouth qi removal, nebula elimination, hiccup regurgitation, accumulated blocks, stasis, ulceration, bone sticking, malignant boil and oral teeth; has antibacterial, toxic materials clearing away, and repercussive effects.
Sanguis Draxonis contains dracorhodin, demethyl dracorhodin, pinoresinoic acid, isopinic acid, abietic acid, sanguis Draxonis flavan A, dehydroabietic acid, isopimaric acid, pimaric acid, and sanguis Draxonis dioxepin; record the sudden cardiac and abdominal pain, the bleeding of incised wound, the blood stasis, the pain and the flesh generation in the New revised materia Medica; the record of the book Guangli Fang from the book Ben Cao Hui Yan (materia Medica of materia Medica) is to treat all incised sores and pyogenic infections and ulcerations without muscle generation: sanguis Draxonis, hair ash, Olibanum, Myrrha, Calomelas, and dens Elephatis powder. A little borneol is mixed into powder; the book Shengjie general book records Xue Xie san: all the diseases are not detected, malignant sores are treated, and the sore is not cured in the deep year: 30 g of dragon's blood and 15 g of red lead (fried purple), smashing the two medicines into powder, washing sores with salt soup and then sticking the sores; modern pharmacological research shows that the dragon's blood can shorten the calcification time of blood plasma; remarkably inhibiting platelet aggregation and preventing thrombosis; improving microcirculation, and inhibiting various pathogenic fungi to different degrees; promoting tissue regeneration and healing wound; relieving pain.
The radix et rhizoma Rhei contains rhein, emodin, aloe-emodin, alpha-catechin, and gallic acid as main ingredients; the "Rihuazi materia Medica" records: dredge all qi, regulate blood vessels, benefit joints, purge plastic stagnation, water-qi, abnormal cold and heat of limbs, warm miasma, heat phlegm, relieve constipation and apply topically to sore, furuncle and carbuncle. 'gang mu Shi Yi' records the new use of removing blood stasis. For traumatic injury, abscess and swelling, bleeding stopping; the record of rhubarb in the Ministry of health and precious medicine records that the chilblain skin is broken and rotten and has intolerable pain: the Chuan Da Huang is smashed and mixed with fresh water, and applied on the cold sores, such as Shen san; modern pharmacological research shows that the action mechanism of the rhubarb is to promote the adhesion and aggregation of blood platelets; increasing platelet count and fibrinogen content; reducing antithrombin III activity; causing vasoconstriction of the injured local area; the bacteriostasis mechanism mainly inhibits the oxidation and dehydrogenation of thalli sugar metabolism intermediate products, inhibits the synthesis of protein and nucleic acid, and inhibits a bacterial biological oxidase system; inducing interferon; the anti-inflammatory action mechanism of rhubarb is mainly related to the inhibition of blood cell aggregation reaction related to arachidonic acid metabolism and the inhibition of oxidase reaction path in cells.
Sanguisorba officinalis contains catechins, 3', 4-tri-0-methyl gallic acid, and is described in the journal of Ou Lu: stopping purulent blood, fistula, malignant boil, eliminating wine, removing thirst, tonifying wound, and puerperal internal obstruction, and can be used as incised wound ointment. The main leakage is not stopped, and the blood is insufficient. Recorded in Ben Cao gang mu, sang Yu can remove heat from lower energizer and treat hemafecia and stool. Stopping bleeding, the cut pieces are taken and stir-baked, and the tip of the cut pieces can move blood. Yang Shiyin cloud: radix Sangusorbae for sore patients, and Scutellariae radix for itching patients; modern pharmacological research shows that sanguisorba has hemostatic effect, anti-inflammatory effect and wound healing promotion. The sanguisorbin I and the isomorphous acid have the effect of promoting thrombopoiesis.
Radix Ampelopsis contains tartaric acid, fumaric acid, gallic acid, etc.; still contains mucoid, starch, tannin, flavonoid glycoside, glucose, etc.; the prescription of Jifeng Puji records 15 g of radix ampelopsis, rhizoma bletillae and Chinese starjasmine stem respectively, and the dry ingredients are taken out. Grinding into fine powder, and scattering on the sore; the "Rihuazi materia Medica" records: stopping convulsion, back attack, scrofula, intestinal wind, anal fistula, knife and arrow sores, acute eczema, warm malaria, bloody dysentery, scald, fire sores, granulation promoting and pain relieving; modern pharmacological research shows that the ampelopsis japonica has a strong inhibition effect on tyrosinase; has effects in resisting pathogenic microorganism, promoting T lymphocyte proliferation and macrophage phagocytosis.
Relevant functional components of the ground beetle: active ingredients such as a plurality of active proteases, 17 amino acids, 12 unsaturated fatty acids, trace elements, alkaloids, fat-soluble vitamins and the like; recorded in Sheng Ji Zong Lu (holy economic book) that the ground dried Eupolyphaga Seu Steleophaga and Moschus are ground into small amount respectively. The two herbs are ground uniformly. Dry blending or sticking, and treating with dry and wet; modern pharmacological research shows that the ground beetles promote blood circulation, cure injuries and regulate inflammatory reaction; the extract can inhibit platelet aggregation and adhesion rate, and reduce aggregation number; the water extract of total alkaloids of Eupolyphaga Seu Steleophaga has antihypoxic effect.
The honeysuckle flower contains luteolin, inositol 1%, volatile oil, terpenes, phenolic acid and other chemical components. Wherein the composition comprises chlorogenic acid, isochlorogenic acid, ginkgol, beta-sitosterol, stigmasterol-D-glucoside, etc.; huichang honeysuckle powder is recorded in Huofan mechanical essences: for sores and ulcers with severe pain and purple-black color: 60g of honeysuckle flower twig and leaf (file), 120 g of astragalus root and 30 g of liquorice. Cutting, adding wine one liter, sealing, decocting for three or two hours, removing residues, and taking immediately; the Chinese angelica flower soup is recorded in Dongtian AoZhi: treating early onset of carbuncle, cellulitis and hair on the back: 240 g of honeysuckle and ten bowls of water are decocted to two bowls, 60g of angelica is added, and the mixture is decocted to one bowl and taken in one dose; the record of Yunnan herbal medicine: clear heat, relieve sores, abscess, deep-rooted carbuncle, hairy dorsum, erysipelas and scrofula. Modern pharmacological research shows that honeysuckle has the functions of antibiosis and inflammatory reaction regulation.
The related functional components of the momordica cochinchinensis seeds are as follows: fatty oils, saponins, sterols, and polysaccharides (trehalose), etc.; the record of the "Yi Zong jin Jian" (medical Zong golden seal): sores and ulcers, swelling and toxin, scrofula, acute mastitis, hemorrhoids, swelling and pain, tinea, and tinea pedis. It can resolve stagnation, resolve swelling, counteract toxic pathogen and cure sore, and promote tissue regeneration and alleviate pain, so it is indicated for the above mentioned diseases. If it is used alone, it is ground into juice with vinegar and applied externally or ground into powder with vinegar and applied to the affected part. For abscess and swelling due to toxin, it is stir-baked into coke and ground into fine powder, and mixed with water for external application, such as Wulong ointment. The record of "Kaibao Bencao" (Kaibao herbal) is: mainly treats fracture, mass and swelling, malignant sore, granulation promoting, lumbago relieving, acne removing, mastitis, anal swelling and pain. Record Shenxiao Qianju Gao from Yi Zong jin Jian: semen momordicae is used for treating sore and ulcer, early stage of furunculosis, scrofula and ecthyma, and arches of children: five ground woodlouse (hulled), four white and tender rosin (cleaned), one copper green ground into one money, two money for frankincense and myrrh, seven money for castor bean (hulled), five grains of croton meat and one money for almond (hulled). Mixing the above eight medicines, and pounding in stone mortar for three thousand times to obtain paste; taking up and soaking in cold water. When in use, the paste is rubbed into thin pieces with hands according to the size of the sore, stuck on the sore and covered with silk. Modern pharmacological research shows that the momordica cochinchinensis seed has the effects of detoxifying, relieving swelling and relieving pain.
Detailed Description
For better explanation of the present invention, the following detailed description of the present invention is provided for understanding.
Example 1, a traditional Chinese medicine compatible component for treating chronic wounds is prepared from the following components in parts by weight: 15 parts of lithospermum, 0.2 part of bezoar, 35 parts of borneol, 0.1 part of pearl powder, 0.3 part of amber powder, 30 parts of angelica, 70 parts of calcined calamine powder, 0.2 part of musk, 15 parts of dragon's blood, 7 parts of rhubarb, 7 parts of garden burnet, 12 parts of Japanese ampelopsis root, 5 parts of ground beeltle, 10 parts of honeysuckle, 1 part of momordica seed and 6 parts of borax.
In the embodiment 2, the traditional Chinese medicine compatible component for treating chronic wound is prepared from the following components in parts by weight: 20 parts of lithospermum, 0.5 part of bezoar, 45 parts of borneol, 0.3 part of pearl powder, 0.5 part of amber powder, 40 parts of angelica, 80 parts of calcined calamine powder, 0.3 part of musk, 20 parts of dragon's blood, 10 parts of rhubarb, 10 parts of sanguisorba, 15 parts of ampelopsis japonica, 10 parts of ground beeltle, 15 parts of honeysuckle, 2 parts of momordica cochinchinensis seeds and 10 parts of borax.
Embodiment 3, the traditional Chinese medicine compatible component for treating chronic wound is prepared from the following components in parts by weight: 35 parts of lithospermum, 5 parts of bezoar, 50 parts of borneol, 1.0 part of pearl powder, 5 parts of amber powder, 60 parts of angelica, 90 parts of calcined calamine powder, 0.6 part of musk, 35 parts of dragon's blood, 15 parts of rheum officinale, 18 parts of garden burnet root, 35 parts of ampelopsis japonica, 15 parts of ground beeltle, 35 parts of honeysuckle, 4 parts of momordica seed and 10 parts of borax.
Example 4, the traditional Chinese medicine compatible component for treating chronic wound is prepared from the following components in parts by weight: 25 parts of lithospermum, 0.7 part of bezoar, 40 parts of borneol, 0.5 part of pearl powder, 0.5 part of amber powder, 50 parts of angelica, 108.6 parts of calcined calamine powder, 0.4 part of musk, 25 parts of dragon's blood, 13 parts of rhubarb, 13 parts of sanguisorba, 25 parts of ampelopsis japonica, 10 parts of ground beeltle, 25 parts of honeysuckle, 3 parts of momordica cochinchinensis and 10 parts of borax.
The preparation method of each embodiment of the invention comprises the following steps:
s1: placing borax in a calcining pot according to the formula amount, heating with strong fire, calcining to form white snow, crisp and loose blocks, taking out, cooling, grinding, sieving with a 200-mesh sieve to obtain powder I, or adding appropriate amount of vaseline to obtain paste I;
s2: grinding Moschus, calculus bovis, radix et rhizoma Rhei, Succinum, sanguis Draxonis, Borneolum Syntheticum, radix Ampelopsis, Eupolyphaga Seu Steleophaga, and semen Momordicae into fine powder P1; pulverizing the calcined calamine powder with the formula amount into fine powder, heating 800g of vaseline and 60g of wool fat, heating to about 150 ℃, slowly adding the calcined calamine powder, stirring, cooling to about 50 ℃, adding the fine powder P1 with the formula amount, and stirring uniformly to form paste II;
s3: soaking radix Arnebiae, radix Angelicae sinensis, and flos Lonicerae in small amount of oleum Sesami for 15-30 days, boiling, cooling to 50 deg.C, keeping for about 20 min, and filtering to obtain extract III;
s4: parching radix Sangusorbae to brown, and grinding into powder IV;
s5: mixing paste I obtained from S1 or paste II obtained from powder I, S2, extract III obtained from S3 and powder IV obtained from S4 to obtain paste.
The traditional Chinese medicine compatible component preparation for treating the chronic wound is an ointment, and an equal amount of Jingwanhong ointment is added for mixing.
The application of the traditional Chinese medicine compatible components for treating chronic wound surfaces can be added with sulfadiazine ointment with the same amount to improve the antiviral effect of the ointment.
The traditional Chinese medicine compatible component for treating the chronic wound is prepared into paste and patches.
The traditional Chinese medicine compatible components are applied to treating chronic wounds.
The traditional Chinese medicine compatible components for treating chronic wounds are clinically used from 1988, and no systemic allergy or local allergy is found in more than 30 years, and no case of damage to important organs of the whole body exists. The invention has more remarkable effect on the recovery of chronic wound surfaces, the dressing change interval is reduced from 2 times a day to once every 3 to 4 days, and the clinical application conditions are as follows:
1. use of infections in diabetic patients, lower limbs or other parts of the body
(1) The fasting blood sugar of the patient is controlled below 8;
(2) applying the medicine after removing necrotic tissues;
(3) the granulation tissue grows fast, no scar is left after healing, and the healing time is 2/3 time faster than normal;
(4) the application patient is close to 200.
2. Application of anorectal patients
(1) Is suitable for perianal abscess incision and after intestinal atrophy (wilting tube excision)
(2) The granulation grows rapidly, the healing time is shortened, the local inflammatory reaction disappears rapidly, and the healing time is shortened;
(3) approximately 300 patients were used.
3. Ulcer of lower limb caused by great saphenous vein varicosity
(1) Ligature of great saphenous vein and sectional stripping of varicose vein
(2) Applying medicine to ulcer part of lower limb after operation, the ulcer healing is rapid
(3) The number of applied patients is more than 100.
4. Application of bedsore patient
(1) Bedsore of long-term bedridden patients
(2) The necrotic tissues and the hardened tissues are clear, the medicine is applied, the granulation grows rapidly and the healing process is accelerated 1/2 time according to the normal bedsore nursing rule.
(3) The number of cases was 26.
5. Wound at far end of limb, wound with poor blood stain and long-term infection
(1) Wound of always cleaning up
(2) Applying the medicine, healing is obviously accelerated
(3) The number of cases is about 200.
6. Application of burn and scald patient
(1) The medicine is applied after I degree and shallow II degree injuries, the healing time is shortened, and no scar is left
(2) Deep II degree burn, the water seepage period is finished, the application is carried out after debridement, and the wet dressing can obviously inhibit infection, accelerate granulation growth and accelerate the falling separation of necrotic tissues;
(3) the number of application examples is more than 200.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents, and thus the embodiments of the present invention are intended to be merely illustrative examples of the invention and are not to be construed as limiting the invention in any way.
Claims (9)
1. A traditional Chinese medicine compatible component for treating chronic wound is characterized in that: the composition is prepared from the following components in parts by weight: 10-50 parts of lithospermum, 0.1-10 parts of bezoar, 30-90 parts of borneol, 0.1-1.0 part of pearl powder, 0.2-5 parts of amber powder, 30-80 parts of angelica, 50-120 parts of calcined calamine powder, 0.1-0.8 part of musk, 10-40 parts of dragon's blood, 5-20 parts of rheum officinale, 5-20 parts of garden burnet root, 10-40 parts of Japanese ampelopsis root, 1-20 parts of ground beetle, 10-40 parts of honeysuckle, 1-5 parts of momordica cochinchinensis seed and 5-20 parts of borax.
2. The traditional Chinese medicine compatible component for treating chronic wounds according to claim 1 is characterized in that: the composition is prepared from the following components in parts by weight: 15-40 parts of lithospermum, 0.3-10 parts of bezoar, 40-80 parts of borneol, 0.3-0.7 part of pearl powder, 0.2-3 parts of amber powder, 40-60 parts of angelica, 70-100 parts of calcined calamine powder, 0.2-0.4 part of musk, 15-30 parts of dragon's blood, 8-18 parts of rheum officinale, 10-20 parts of garden burnet root, 15-30 parts of Japanese ampelopsis root, 5-15 parts of ground beetle, 15-30 parts of honeysuckle, 1-5 parts of momordica seed and 10 parts of borax.
3. The traditional Chinese medicine compatible component for treating chronic wounds according to claim 1 is characterized in that: the composition is prepared from the following components in parts by weight: 15-30 parts of lithospermum, 0.3-10 parts of bezoar, 30-50 parts of borneol, 0.3-0.7 part of pearl powder, 0.2-3 parts of amber powder, 40-60 parts of angelica, 90-110 parts of calcined calamine powder, 0.2-0.4 part of musk, 18-28 parts of dragon's blood, 10-15 parts of rheum officinale, 10-15 parts of garden burnet root, 20-30 parts of Japanese ampelopsis root, 8-15 parts of ground beetle, 20-30 parts of honeysuckle, 1-5 parts of momordica seed and 10 parts of borax.
4. The traditional Chinese medicine compatible component for treating chronic wounds according to claim 1 is characterized in that: the composition is prepared from the following components in parts by weight: 25 parts of lithospermum, 0.7 part of bezoar, 40 parts of borneol, 0.5 part of pearl powder, 0.5 part of amber powder, 50 parts of angelica, 108.6 parts of calcined calamine powder, 0.4 part of musk, 25 parts of dragon's blood, 13 parts of rhubarb, 13 parts of sanguisorba, 25 parts of ampelopsis japonica, 10 parts of ground beeltle, 25 parts of honeysuckle, 3 parts of momordica cochinchinensis and 10 parts of borax.
5. The process for preparing a Chinese medicinal composition for treating chronic wounds according to any one of claims 1 to 4, wherein: the method comprises the following steps:
s1: placing borax in a calcining pot according to the formula amount, heating with strong fire, calcining to form white snow, crisp and loose blocks, taking out, cooling, grinding, sieving with a 200-mesh sieve to obtain powder I, or adding appropriate amount of vaseline to obtain paste I;
s2: grinding Moschus, calculus bovis, radix et rhizoma Rhei, Succinum, sanguis Draxonis, Borneolum Syntheticum, radix Ampelopsis, Eupolyphaga Seu Steleophaga, and semen Momordicae into fine powder P1; pulverizing the calcined calamine powder with the formula amount into fine powder, heating 800g of vaseline and 60g of wool fat, heating to about 150 ℃, slowly adding the calcined calamine powder, stirring, cooling to about 50 ℃, adding the fine powder P1 with the formula amount, and stirring uniformly to form paste II;
s3: soaking radix Arnebiae, radix Angelicae sinensis, and flos Lonicerae in small amount of oleum Sesami for 15-30 days, boiling, cooling to 50 deg.C, keeping for about 20 min, and filtering to obtain extract III;
s4: parching radix Sangusorbae to brown, and grinding into powder IV;
s5: mixing paste I obtained from S1 or paste II obtained from powder I, S2, extract III obtained from S3 and powder IV obtained from S4 to obtain paste.
6. The use of the compatible ingredients of chinese herbs for the treatment of chronic wounds according to any one of claims 1 to 4, wherein: the traditional Chinese medicine compatible component preparation is ointment, and the same amount of Jingwanhong ointment is added for mixing.
7. The use of the compatible ingredients of chinese herbs for the treatment of chronic wounds as claimed in claim 6, wherein: sulfadiazine ointment may also be added to raise the antiviral effect of the ointment.
8. A herbal formulation for use in the treatment of chronic wounds, according to any one of claims 1 to 4, wherein: the Chinese medicinal compatible component preparation is paste or patch.
9. The use of the herbal compatible ingredients of any one of claims 1 to 4 for the treatment of chronic wounds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010164496.1A CN112933169A (en) | 2020-03-11 | 2020-03-11 | Traditional Chinese medicine compatible component for treating chronic wound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010164496.1A CN112933169A (en) | 2020-03-11 | 2020-03-11 | Traditional Chinese medicine compatible component for treating chronic wound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112933169A true CN112933169A (en) | 2021-06-11 |
Family
ID=76234492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010164496.1A Pending CN112933169A (en) | 2020-03-11 | 2020-03-11 | Traditional Chinese medicine compatible component for treating chronic wound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112933169A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1640437A (en) * | 2004-01-18 | 2005-07-20 | 中国人民解放军军事医学科学院毒物药物研究所 | Medicinal composition for treating gastro intestinal tract disease |
CN108619362A (en) * | 2018-06-29 | 2018-10-09 | 利辛县运杰家庭农场 | A kind of acne cream and preparation method thereof |
CN109200159A (en) * | 2018-10-30 | 2019-01-15 | 王心海 | A kind of ointment for burns and scalds and preparation method thereof |
CN110179900A (en) * | 2018-03-26 | 2019-08-30 | 何本仁 | A kind of ointment for treating burn and scald and preparation method thereof |
-
2020
- 2020-03-11 CN CN202010164496.1A patent/CN112933169A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1640437A (en) * | 2004-01-18 | 2005-07-20 | 中国人民解放军军事医学科学院毒物药物研究所 | Medicinal composition for treating gastro intestinal tract disease |
CN110179900A (en) * | 2018-03-26 | 2019-08-30 | 何本仁 | A kind of ointment for treating burn and scald and preparation method thereof |
CN108619362A (en) * | 2018-06-29 | 2018-10-09 | 利辛县运杰家庭农场 | A kind of acne cream and preparation method thereof |
CN109200159A (en) * | 2018-10-30 | 2019-01-15 | 王心海 | A kind of ointment for burns and scalds and preparation method thereof |
Non-Patent Citations (6)
Title |
---|
中国医药公司: "《药品养护》", 31 March 1982, 中国财政经济出版社 * |
任胜林: "关于11例烧烫伤患者的疗效观察", 《中国医药指南》 * |
周美儿: "麝香痔疮膏治疗Ⅱ~Ⅲ度褥疮17例体会", 《现代中西医结合杂志》 * |
王淑霞 等: "马应龙麝香痔疮膏在小面积深Ⅱ°烧伤患者中的应用", 《中国中医药现代远程教育》 * |
程慧洁 等: "马应龙麝香痔疮膏临床新用", 《浙江中医杂志》 * |
马振友 等: "《新编中西皮肤药物手册》", 31 January 2019, 河南科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6027728A (en) | Herbal skin regeneration composition and method | |
CN103393953B (en) | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof | |
CN102091203A (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
CN101310748B (en) | Ointment for treating empyrosis | |
CN102228485A (en) | Composition for burn rehabilitation and preparation method thereof | |
CN109316555B (en) | External traditional Chinese medicine preparation for promoting healing of chronic skin ulcer wound and preparation method thereof | |
CN106581439A (en) | Traditional Chinese medicine composition for treating wounds, diabetic feet and skin ulceration, and preparation method thereof | |
CN104958418A (en) | Traditional Chinese herbal medicine ointment for treating burns and scalds | |
CN110652552A (en) | Wound healing formula and preparation method | |
CN112933169A (en) | Traditional Chinese medicine compatible component for treating chronic wound | |
CN103721067B (en) | A kind of diabetic foot care Chinese medicine composition | |
CN108186901B (en) | A compound preparation containing Artemisia Selengensis for treating burn and scald, and its preparation method | |
CN105853866A (en) | Method for preparing Chinese herbal medicine composition for treating bedsore | |
CN104800427A (en) | Burn and scald recovery application and preparation method thereof | |
CN104873723B (en) | A kind of burn-scald medicine containing cinnamon oil | |
CN100488547C (en) | Pharmaceutical composition for treating tinea and complication thereof | |
CN111265644A (en) | Bone-activating pain-relieving plaster and preparation method thereof | |
CN109908312B (en) | Hemorrhoid ointment and preparation method thereof | |
CN114533859B (en) | Traditional Chinese medicine ointment for treating hemorrhoids and preparation method thereof | |
CN115887601B (en) | A composition for treating hemorrhoid and its preparation method | |
CN108066466A (en) | A kind of Chinese medicine composition for treating burn and scald and preparation method and application | |
CN113332365B (en) | Compound lithospermum ointment and preparation method thereof | |
CN108186900B (en) | A compound preparation containing Artemisia Selengensis for treating burn and scald, and its preparation method | |
CN116173146A (en) | External-use scar-free traditional Chinese medicine ointment for burns and scalds and preparation method thereof | |
CN105193996A (en) | Traditional Chinese medicine composition for treating decubitus and preparation method of traditional Chinese medicine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210611 |